YaoGeJu

Company directoryChina company filings

Hinye Pharmaceutical Co.,Ltd.

As of 18 November 2026, for the company name Hinye Pharmaceutical Co.,Ltd. as recorded, the chemical-drug catalogue lists 27 active records with this name as holder; 20 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

42 acceptance records as first applicant, grouped into 30 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Empagliflozin Tablets 5 records · Latest accepted 2026/11/17

Supplement · 3Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2602093Supplement2026/11/17Hinye Pharmaceutical Co.,Ltd.CDE ↗
CYHB2602092Supplement2026/11/17Hinye Pharmaceutical Co.,Ltd.CDE ↗
CYHB2302357Supplement2023/10/25Hinye Pharmaceutical Co.,Ltd.CDE ↗
CYHS2200114Generic2022/01/18Hinye Pharmaceutical Co.,Ltd.CDE ↗
CYHS2200113Generic2022/01/18Hinye Pharmaceutical Co.,Ltd.CDE ↗
小儿清热消炎宁颗粒 · No verified English name 1 records · Latest accepted 2026/10/29

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXZS2600057New drug2026/10/29Hinye Pharmaceutical Co.,Ltd.CDE ↗
Acarbose Tablets 1 records · Latest accepted 2026/10/22

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602591Generic2026/10/22Hinye Pharmaceutical Co.,Ltd.CDE ↗
活络消痛胶囊 · No verified English name 2 records · Latest accepted 2026/03/19

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2600936Supplement2026/03/19Hinye Pharmaceutical Co.,Ltd.CDE ↗
CYZB2101071Supplement2021/04/27Hinye Pharmaceutical Co.,Ltd.CDE ↗
Dotinurad Tablets 2 records · Latest accepted 2025/12/30

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2504481Generic2025/12/30Hinye Pharmaceutical Co.,Ltd.CDE ↗
CYHS2503112Generic2025/08/25Hinye Pharmaceutical Co.,Ltd.CDE ↗
Baricitinib Tablets 1 records · Latest accepted 2025/10/31

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503843Generic2025/10/31Hinye Pharmaceutical Co.,Ltd.CDE ↗
独一味胶囊 · No verified English name 1 records · Latest accepted 2025/06/14

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZS2500007Generic2025/06/14Hinye Pharmaceutical Co.,Ltd.CDE ↗
Finerenone Tablets 1 records · Latest accepted 2024/12/19

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2404406Generic2024/12/19Hinye Pharmaceutical Co.,Ltd.CDE ↗
Vonoprazan Fumarate Tablets 1 records · Latest accepted 2024/10/12

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403416Generic2024/10/12Hinye Pharmaceutical Co.,Ltd.CDE ↗
Glucosamine Sulfate Capsules 1 records · Latest accepted 2024/10/11

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403382Generic2024/10/11Hinye Pharmaceutical Co.,Ltd.CDE ↗
Dapagliflozin Tablets 1 records · Latest accepted 2024/07/26

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402364Generic2024/07/26Hinye Pharmaceutical Co.,Ltd.CDE ↗
注射用HYH2006078P1 · No verified English name 1 records · Latest accepted 2024/01/31

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2400124New drug2024/01/31Hinye Pharmaceutical Co.,Ltd.CDE ↗
Upadacitinib Sustained-release Tablets 1 records · Latest accepted 2024/01/06

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400083Generic2024/01/06Hinye Pharmaceutical Co.,Ltd.CDE ↗
HYR04胶囊 · No verified English name 1 records · Latest accepted 2023/07/20

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXZL2300051New drug2023/07/20Hinye Pharmaceutical Co.,Ltd.CDE ↗
HYZ2001胶囊 · No verified English name 1 records · Latest accepted 2023/04/24

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXZL2300030New drug2023/04/24Hinye Pharmaceutical Co.,Ltd.CDE ↗
HYR0201颗粒 · No verified English name 1 records · Latest accepted 2023/01/20

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXZL2300003New drug2023/01/20Hinye Pharmaceutical Co.,Ltd.CDE ↗
Sildenafil Citrate Oral Disintegrating Tablets 1 records · Latest accepted 2022/07/28

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201165Generic2022/07/28Hinye Pharmaceutical Co.,Ltd.CDE ↗
Apixaban Tablets 1 records · Latest accepted 2022/07/25

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201093Generic2022/07/25Hinye Pharmaceutical Co.,Ltd.CDE ↗
Levetiracetam Tablets 2 records · Latest accepted 2022/06/21

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200921Generic2022/06/21Hinye Pharmaceutical Co.,Ltd.CDE ↗
CYHS2200920Generic2022/06/21Hinye Pharmaceutical Co.,Ltd.CDE ↗
Oseltamivir Phosphate Capsules 1 records · Latest accepted 2022/04/26

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200645Generic2022/04/26Hinye Pharmaceutical Co.,Ltd.CDE ↗
Rivaroxaban Tablets 2 records · Latest accepted 2022/04/13

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200574Generic2022/04/13Hinye Pharmaceutical Co.,Ltd.CDE ↗
CYHS2200573Generic2022/04/13Hinye Pharmaceutical Co.,Ltd.CDE ↗
Escitalopram Oxalate Tablets 2 records · Latest accepted 2022/02/23

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200365Generic2022/02/23Hinye Pharmaceutical Co.,Ltd.CDE ↗
CYHS2200364Generic2022/02/23Hinye Pharmaceutical Co.,Ltd.CDE ↗
Rosuvastatin Calcium Tablets 2 records · Latest accepted 2022/02/10

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200296Generic2022/02/10Hinye Pharmaceutical Co.,Ltd.CDE ↗
CYHS2200295Generic2022/02/10Hinye Pharmaceutical Co.,Ltd.CDE ↗
铝碳酸镁颗粒 · No verified English name 1 records · Latest accepted 2021/09/02

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150837Supplement2021/09/02Hinye Pharmaceutical Co.,Ltd.CDE ↗
Tenofovir alafenamide Fumarate Tablets 1 records · Latest accepted 2021/04/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101117Generic2021/04/30Hinye Pharmaceutical Co.,Ltd.CDE ↗
复方益肝灵胶囊 · No verified English name 1 records · Latest accepted 2021/04/27

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2101073Supplement2021/04/27Hinye Pharmaceutical Co.,Ltd.CDE ↗
清热消炎宁片 · No verified English name 1 records · Latest accepted 2021/04/27

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2101070Supplement2021/04/27Hinye Pharmaceutical Co.,Ltd.CDE ↗
炎可宁丸 · No verified English name 1 records · Latest accepted 2021/04/27

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2101072Supplement2021/04/27Hinye Pharmaceutical Co.,Ltd.CDE ↗
Memantine Hydrochloride Tablets 1 records · Latest accepted 2021/01/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2100088Generic2021/01/21Hinye Pharmaceutical Co.,Ltd.CDE ↗
Pregabalin Capsules 3 records · Latest accepted 2021/01/11

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2100028Generic2021/01/11Hinye Pharmaceutical Co.,Ltd.CDE ↗
CYHS2100027Generic2021/01/11Hinye Pharmaceutical Co.,Ltd.CDE ↗
CYHS2100026Generic2021/01/11Hinye Pharmaceutical Co.,Ltd.CDE ↗

Changes in the last 90 days

4 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 4 applications

  1. 2026/11/17Accepted

    Empagliflozin Tablets

    CYHB2602093

    Fact date: 2026/11/17 · Date added to this site: 2026/11/18

    View source ↗
  2. 2026/11/17Accepted

    Empagliflozin Tablets

    CYHB2602092

    Fact date: 2026/11/17 · Date added to this site: 2026/11/18

    View source ↗
  3. 2026/10/29Accepted

    小儿清热消炎宁颗粒 · No verified English name

    CXZS2600057

    Fact date: 2026/10/29 · Date added to this site: 2026/10/30

    View source ↗
  4. 2026/10/22Accepted

    Acarbose Tablets

    CYHS2602591

    Fact date: 2026/10/22 · Date added to this site: 2026/10/23

    View source ↗

Under review

10 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Empagliflozin Tablets CYHB2602093Supplement2026/11/17Hinye Pharmaceutical Co.,Ltd.CDE ↗
Empagliflozin Tablets CYHB2602092Supplement2026/11/17Hinye Pharmaceutical Co.,Ltd.CDE ↗
小儿清热消炎宁颗粒 · No verified English name CXZS2600057New drug2026/10/29Hinye Pharmaceutical Co.,Ltd.CDE ↗
Acarbose Tablets CYHS2602591Generic2026/10/22Hinye Pharmaceutical Co.,Ltd.CDE ↗
Dotinurad Tablets CYHS2504481Generic2025/12/30Hinye Pharmaceutical Co.,Ltd.CDE ↗
Baricitinib Tablets CYHS2503843Generic2025/10/31Hinye Pharmaceutical Co.,Ltd.CDE ↗
Dotinurad Tablets CYHS2503112Generic2025/08/25Hinye Pharmaceutical Co.,Ltd.CDE ↗
独一味胶囊 · No verified English name CYZS2500007Generic2025/06/14Hinye Pharmaceutical Co.,Ltd.CDE ↗
Finerenone Tablets CYHS2404406Generic2024/12/19Hinye Pharmaceutical Co.,Ltd.CDE ↗
Upadacitinib Sustained-release Tablets CYHS2400083Generic2024/01/06Hinye Pharmaceutical Co.,Ltd.CDE ↗

Catalogue holder records

27 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Vonoprazan Fumarate TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202632482026/01/27Generic approved under the new chemical-drug registration classificationCDE ↗
Glucosamine Sulfate CapsulesHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202562452025/12/16Generic approved under the new chemical-drug registration classificationCDE ↗
Dapagliflozin TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202552932025/09/02Generic approved under the new chemical-drug registration classificationCDE ↗
Empagliflozin TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202471612024/07/11Generic approved under the new chemical-drug registration classificationCDE ↗
Apixaban TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202346532023/12/13Generic approved under the new chemical-drug registration classificationCDE ↗
Levetiracetam TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202345992023/12/05Generic approved under the new chemical-drug registration classificationCDE ↗
Levetiracetam TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202346002023/12/05Generic approved under the new chemical-drug registration classificationCDE ↗
Rivaroxaban TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202343292023/10/18Generic approved under the new chemical-drug registration classificationCDE ↗
Rivaroxaban TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202343282023/10/18Generic approved under the new chemical-drug registration classificationCDE ↗
Escitalopram Oxalate TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202340632023/08/29Generic approved under the new chemical-drug registration classificationCDE ↗
Oseltamivir Phosphate CapsulesHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202340702023/08/29Generic approved under the new chemical-drug registration classificationCDE ↗
Escitalopram Oxalate TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202340622023/08/29Generic approved under the new chemical-drug registration classificationCDE ↗
Empagliflozin TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202335072023/04/28Generic approved under the new chemical-drug registration classificationCDE ↗
Rosuvastatin Calcium TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202334952023/04/17Generic approved under the new chemical-drug registration classificationCDE ↗
Rosuvastatin Calcium TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202334942023/04/17Generic approved under the new chemical-drug registration classificationCDE ↗
Tenofovir alafenamide Fumarate TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202332782023/03/15Generic approved under the new chemical-drug registration classificationCDE ↗
铝碳酸镁颗粒 · No verified English nameHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H201131862022/09/19Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Memantine Hydrochloride TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202234062022/06/16Generic approved under the new chemical-drug registration classificationCDE ↗
Pregabalin CapsulesHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202233052022/05/10Generic approved under the new chemical-drug registration classificationCDE ↗
Pregabalin CapsulesHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202233062022/05/10Generic approved under the new chemical-drug registration classificationCDE ↗
Pregabalin CapsulesHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202233072022/05/10Generic approved under the new chemical-drug registration classificationCDE ↗
Tofacitinib Citrate TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202133602021/05/11Generic approved under the new chemical-drug registration classificationCDE ↗
Lamivudine TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202036882020/12/15Generic approved under the new chemical-drug registration classificationCDE ↗
Entecavir TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202034082020/08/12Generic approved under the new chemical-drug registration classificationCDE ↗
Entecavir TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202034072020/08/12Generic approved under the new chemical-drug registration classificationCDE ↗
Atorvastatin Calcium TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202033582020/07/29Generic approved under the new chemical-drug registration classificationCDE ↗
Sildenafil Citrate Oral Disintegrating TabletsHinye Pharmaceutical Co.,Ltd.Hinye Pharmaceutical Co.,Ltd.国药准字H202345672023/11/28Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

20 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
L-焦谷氨酸艾托格列净 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20250001319I2025/12/23CDE ↗
多替诺雷 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20250000660A2026/10/12CDE ↗
腺苷 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20250000400I2025/04/28CDE ↗
乌帕替尼 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20240001316A2026/06/23CDE ↗
富马酸伏诺拉生 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20240000949A2025/12/17CDE ↗
非奈利酮 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20240000913A2026/03/26CDE ↗
达格列净 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20240000242A2025/09/04CDE ↗
巴瑞替尼 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20240000146A2026/07/16CDE ↗
乌帕替尼 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20230000796A2026/06/23CDE ↗
恩格列净 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20210001202A2026/07/02CDE ↗
利伐沙班 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20210001204A2024/06/15CDE ↗
阿哌沙班 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20210000698A2024/06/15CDE ↗
富马酸丙酚替诺福韦 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20210000047A2025/08/28CDE ↗
坎地沙坦酯 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20190007467A2024/01/27CDE ↗
甲苯磺酸妥舒沙星 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20190006533A2026/08/04CDE ↗
枸橼酸托法替布 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20190000509A2026/05/09CDE ↗
塞来昔布 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20180001654I2019/03/13CDE ↗
盐酸乐卡地平 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20170001301A2024/04/29CDE ↗
米力农 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20170001190A2023/07/15CDE ↗
盐酸法舒地尔 · No verified English nameHinye Pharmaceutical Co.,Ltd.Y20170000283A2023/12/05CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

4 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
唑尼沙胺胶囊 · No verified English name CYHS2601662Generic2026/07/13Hunan Shang Zhong He Biopharmaceuticals Co., Ltd. romanized; Hinye Pharmaceutical Co.,Ltd.CDE ↗
唑尼沙胺片 · No verified English name CYHS2504341Generic2025/12/22Hunan Shang Zhong He Biopharmaceuticals Co., Ltd. romanized; Hinye Pharmaceutical Co.,Ltd.CDE ↗
复方聚乙二醇电解质散(II) · No verified English name CYHS2501876Generic2025/05/27Hunan Run Xing Pharma Co., Ltd. romanized; Hinye Pharmaceutical Co.,Ltd.CDE ↗
Sildenafil Citrate Oral Disintegrating Tablets CYHB2402166Supplement2024/12/19Hubei Fu Rui Long Pharma Co., Ltd. romanized; Hinye Pharmaceutical Co.,Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.